NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/04/2024
Back to search
Official data from USPTO
MADRIGAL PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
06/04/2024
Trademark type
Combined
Nice classes
5
Filing date
05/05/2023
Registration date
06/04/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/04/2024
Last transaction
06/04/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
08/14/2020
First use in commerce
08/14/2020
Drawing code
3
Owner type
03
Owner location
West Conshohocken, PA
Examiner
SCHUTZ,MARISA C
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a stylized circle with five lines cutting through the middle of the circle next to the wording "MADRIGAL" with the wording "PHARMACEUTICALS" underneath of "MADRIGAL".
Holders and representatives
Holders
Madrigal Pharmaceuticals, Inc.
Representatives
ANITA B. POLOTT MORGAN, LEWIS & BOCKIUS LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/04/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/19/2024
PUBO
PUBLISHED FOR OPPOSITION
03/19/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/28/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/28/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/12/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
01/31/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/31/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
01/31/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/31/2024
DOCK
ASSIGNED TO EXAMINER
01/31/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/06/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/05/2023
NWAP
NEW APPLICATION ENTERED
05/09/2023
Continuous trademark protection
Get notified about every new filing that threatens MADRIGAL PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.